Trial intelligence / Profile preview

Testosterone plus vitamin D for bone mineral density in hypogonadal men with vitamin D insufficiency

KCT0011855Phase 3Not yet recruiting

Sponsor
St Vincent's Hospital
Start
Aug 2026
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of testosterone, vitamin d in osteopenia, osteoporosis, Hypoandrogenism (TD), Vitamin D deficiency (VDD), sponsored by St Vincent's Hospital. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

testosteronevitamin d
03

Conditions

osteopeniaosteoporosisHypoandrogenism (TD)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on KCT0011855.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0011855.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call